Defective vaccinia virus particles in interferon-treated infected cells
- PMID: 6702105
- DOI: 10.1016/0042-6822(84)90443-4
Defective vaccinia virus particles in interferon-treated infected cells
Abstract
Vaccinia virus particles formed in interferon-treated, infected cells have been isolated. These particles have been characterized with regard to polypeptide composition, and ability to adsorb, penetrate, uncoat, and synthesize proteins in infected cells. As determined by one-dimensional SDS-PAGE analysis, with interferon concentrations of 100-500 u/ml, the pattern of [35S]methionine-labeled virion proteins was not altered; higher doses of interferon resulted in decreased labeling of some proteins. However, interferon doses of 100-500 u/ml decreased phosphorylation of vaccinia virus basic core polypeptide (P-11) by 30-70%; the same doses of interferon decreased the labeling of virus glycoproteins by 40-80%. Virus purified from interferon-treated cells adsorb, penetrate, and uncoat to a lesser extent than virus control. During infection to cells, these virus particles caused shutoff and synthesized the same spectrum of viral proteins as normal virus. These findings show that there are protein alterations in vaccinia virus particles isolated from interferon-treated, infected cells. These alterations may contribute to limit the spread of virus infection.
Similar articles
-
Interferon inhibits marker rescue of vaccinia virus.J Interferon Res. 1985 Spring;5(2):247-56. doi: 10.1089/jir.1985.5.247. J Interferon Res. 1985. PMID: 4009001
-
Analysis of replicating vaccinia DNA in interferon-treated, virus-infected cells.J Interferon Res. 1984 Spring;4(2):179-92. doi: 10.1089/jir.1984.4.179. J Interferon Res. 1984. PMID: 6747347
-
Vaccinia rescue of VSV from interferon-induced resistance: reversal of translation block and inhibition of protein kinase activity.Virology. 1983 Nov;131(1):128-36. doi: 10.1016/0042-6822(83)90539-1. Virology. 1983. PMID: 6316646
-
The conserved poxvirus L3 virion protein is required for transcription of vaccinia virus early genes.J Virol. 2005 Dec;79(23):14719-29. doi: 10.1128/JVI.79.23.14719-14729.2005. J Virol. 2005. PMID: 16282472 Free PMC article.
-
Vaccinia Virus Protein C6: A Multifunctional Interferon Antagonist.Adv Exp Med Biol. 2018;1052:1-7. doi: 10.1007/978-981-10-7572-8_1. Adv Exp Med Biol. 2018. PMID: 29785476 Review.
Cited by
-
Multi-modal cryo-EM reveals trimers of protein A10 to form the palisade layer in poxvirus cores.Nat Struct Mol Biol. 2024 Jul;31(7):1114-1123. doi: 10.1038/s41594-023-01201-6. Epub 2024 Feb 5. Nat Struct Mol Biol. 2024. PMID: 38316877 Free PMC article.
-
The vaccinia virus 14-kilodalton (A27L) fusion protein forms a triple coiled-coil structure and interacts with the 21-kilodalton (A17L) virus membrane protein through a C-terminal alpha-helix.J Virol. 1998 Dec;72(12):10126-37. doi: 10.1128/JVI.72.12.10126-10137.1998. J Virol. 1998. PMID: 9811753 Free PMC article.
-
Cryo-electron tomography of vaccinia virus.Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2772-7. doi: 10.1073/pnas.0409825102. Epub 2005 Feb 7. Proc Natl Acad Sci U S A. 2005. PMID: 15699328 Free PMC article.
-
Interferon prevents the generation of spontaneous deletions at the left terminus of vaccinia virus DNA.J Virol. 1985 Oct;56(1):75-84. doi: 10.1128/JVI.56.1.75-84.1985. J Virol. 1985. PMID: 3861876 Free PMC article.
-
Involvement of PKR and RNase L in translational control and induction of apoptosis after Hepatitis C polyprotein expression from a vaccinia virus recombinant.Virol J. 2005 Sep 12;2:81. doi: 10.1186/1743-422X-2-81. Virol J. 2005. PMID: 16156900 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials